Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/28117
Title: Lifetime Risk Factors for Pre- and Post-Bronchodilator Lung Function Decline. A Population-based Study.
Austin Authors: Bui, Dinh S;Perret, Jennifer L ;Walters, E Haydn;Abramson, Michael J;Burgess, John A;Bui, Minh Q;Bowatte, Gayan;Lowe, Adrian J;Russell, Melissa A;Alif, Sheikh M;Thompson, Bruce R;Hamilton, Garun S;Giles, Graham G;Thomas, Paul S;Morrison, Stephen;Johns, David P;Knibbs, Luke D;Zock, Jan-Paul;Marcon, Alessandro;Garcia-Aymerich, Judith;Erbas, Bircan;Jarvis, Deborah;Svanes, Cecilie;Lodge, Caroline J;Dharmage, Shyamali C
Affiliation: Institute for Breathing and Sleep..
University of Queensland, Brisbane, Queensland, Australia..
Department of Respiratory Medicine, School of Medicine, Flinders University, Adelaide, South Australia, Australia..
School of Public Health, the University of Queensland, Brisbane, Queensland, Australia..
School of Psychology and Public Health, La Trobe University, Melbourne, Victoria, Australia..
Respiratory Epidemiology and Public Health Group, National Heart and Lung Institute, Imperial College London, London, United Kingdom..
Unit of Epidemiology and Medical Statistics, Department of Diagnostics and Public Health, University of Verona, Verona, Italy..
Allergy and Lung Health Unit, The University of Melbourne, Melbourne, Victoria, Australia..
Department of Epidemiology and Biostatistics, MRC-PHE Centre for Environment and Health, School of Public Health..
Centre for International Health, Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway..
Department of Occupational Medicine, Haukeland University Hospital, Bergen, Norway..
Department of Analytical Chemistry and Toxicology, Hanoi University of Pharmacy, Hanoi, Vietnam..
School of Clinical Sciences, Monash Health, Melbourne, Victoria, Australia..
Monash Lung and Sleep, Monash Health, Melbourne, Victoria, Australia..
Precision Medicine, School of Clinical Sciences at Monash Health, Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia..
Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia..
Prince of Wales Hospital Clinical School and School of Medical Sciences, University of New South Wales, Sydney, New South Wales, Australia..
ISGlobal, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain..
Universitat Pompeu Fabra (UPF), Barcelona, Spain..
Central Clinical School, Monash University, Melbourne, Victoria, Australia..
Allergy, Immunology, and Respiratory Medicine, The Alfred Hospital, Melbourne, Victoria, Australia..
School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia...
CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain..
Issue Date: Mar-2020
Publication information: Annals of the American Thoracic Society 2020; 17(3): 302-312.
Abstract: Rationale: Interactions between early life and adult insults on lung function decline are not well understood, with most studies investigating prebronchodilator (pre-BD) FEV1 decline.Objectives: To investigate relationships between adult risk factors and pre- and post-BD lung function decline and their potential effect modification by early life and genetic factors.Methods: Multiple regression was used to examine associations between adult exposures (asthma, smoking, occupational exposures, traffic pollution, and obesity) and decline in both pre- and post-BD spirometry (forced expiratory volume in 1 s [FEV1], forced vital capacity [FVC], and FEV1/FVC) between ages 45 and 53 years in the Tasmanian Longitudinal Health Study (n = 857). Effect modification of these relationships by childhood respiratory risk factors, including low childhood lung function and GST (glutathione S-transferase) gene polymorphisms, was investigated.Results: Baseline asthma, smoking, occupational exposure to vapors/gases/dusts/fumes, and living close to traffic were associated with accelerated decline in both pre- and post-BD FEV1. These factors were also associated with FEV1/FVC decline. Occupational exposure to aromatic solvents was associated with pre-BD but not post-BD FEV1 decline. Maternal smoking accentuated the effect of personal smoking on pre- and post-BD FEV1 decline. Lower childhood lung function and having the GSTM1 null allele accentuated the effect of occupational exposure to vapors/gases/dusts/fumes and personal smoking on post-BD FEV1 decline. Incident obesity was associated with accelerated decline in FEV1 and more pronounced in FVC.Conclusions: This study provides new evidence for accentuation of individual susceptibility to adult risk factors by low childhood lung function, GSTM1 genotype, and maternal smoking.
URI: https://ahro.austin.org.au/austinjspui/handle/1/28117
DOI: 10.1513/AnnalsATS.201904-329OC
ORCID: 0000-0002-4388-784X
0000-0002-7097-4586
0000-0001-6063-1937
0000-0001-7034-0615
Journal: Annals of the American Thoracic Society
PubMed URL: 31800292
PubMed URL: https://pubmed.ncbi.nlm.nih.gov/31800292/
Type: Journal Article
Subjects: bronchodilator
decline
interaction
lung function
susceptibility
Appears in Collections:Journal articles

Show full item record

Page view(s)

16
checked on Nov 25, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.